455 related articles for article (PubMed ID: 29049843)
1. Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications.
Fischer GM; Vashisht Gopal YN; McQuade JL; Peng W; DeBerardinis RJ; Davies MA
Pigment Cell Melanoma Res; 2018 Jan; 31(1):11-30. PubMed ID: 29049843
[TBL] [Abstract][Full Text] [Related]
2. Melanoma Metabolism: Cell Survival and Resistance to Therapy.
Luís R; Brito C; Pojo M
Adv Exp Med Biol; 2020; 1219():203-223. PubMed ID: 32130701
[TBL] [Abstract][Full Text] [Related]
3. Metabolic flexibility in melanoma: A potential therapeutic target.
Ruocco MR; Avagliano A; Granato G; Vigliar E; Masone S; Montagnani S; Arcucci A
Semin Cancer Biol; 2019 Dec; 59():187-207. PubMed ID: 31362075
[TBL] [Abstract][Full Text] [Related]
4. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
[TBL] [Abstract][Full Text] [Related]
5. The tumour immune landscape and its implications in cutaneous melanoma.
Attrill GH; Ferguson PM; Palendira U; Long GV; Wilmott JS; Scolyer RA
Pigment Cell Melanoma Res; 2021 May; 34(3):529-549. PubMed ID: 32939993
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment.
Marzagalli M; Ebelt ND; Manuel ER
Semin Cancer Biol; 2019 Dec; 59():236-250. PubMed ID: 31404607
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial oxidative phosphorylation in cutaneous melanoma.
Kumar PR; Moore JA; Bowles KM; Rushworth SA; Moncrieff MD
Br J Cancer; 2021 Jan; 124(1):115-123. PubMed ID: 33204029
[TBL] [Abstract][Full Text] [Related]
8. Acidic tumor microenvironment in human melanoma.
Böhme I; Bosserhoff AK
Pigment Cell Melanoma Res; 2016 Sep; 29(5):508-23. PubMed ID: 27233233
[TBL] [Abstract][Full Text] [Related]
9. Additive Role of Immune System Infiltration and Angiogenesis in Uveal Melanoma Progression.
García-Mulero S; Alonso MH; Del Carpio LP; Sanz-Pamplona R; Piulats JM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800878
[TBL] [Abstract][Full Text] [Related]
10. Enhancing CD8
Zhang Y; Kurupati R; Liu L; Zhou XY; Zhang G; Hudaihed A; Filisio F; Giles-Davis W; Xu X; Karakousis GC; Schuchter LM; Xu W; Amaravadi R; Xiao M; Sadek N; Krepler C; Herlyn M; Freeman GJ; Rabinowitz JD; Ertl HCJ
Cancer Cell; 2017 Sep; 32(3):377-391.e9. PubMed ID: 28898698
[TBL] [Abstract][Full Text] [Related]
11. Inflammation-Induced Plasticity in Melanoma Therapy and Metastasis.
Hölzel M; Tüting T
Trends Immunol; 2016 Jun; 37(6):364-374. PubMed ID: 27151281
[TBL] [Abstract][Full Text] [Related]
12. The role of lncRNAs in the tumor microenvironment and immunotherapy of melanoma.
Zhou W; Xu X; Cen Y; Chen J
Front Immunol; 2022; 13():1085766. PubMed ID: 36601121
[TBL] [Abstract][Full Text] [Related]
13. Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model.
Yan J; Tingey C; Lyde R; Gorham TC; Choo DK; Muthumani A; Myles D; Weiner LP; Kraynyak KA; Reuschel EL; Finkel TH; Kim JJ; Sardesai NY; Ugen KE; Muthumani K; Weiner DB
Cancer Gene Ther; 2014 Dec; 21(12):507-17. PubMed ID: 25394503
[TBL] [Abstract][Full Text] [Related]
14. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
15. Tumor hypermetabolism confers resistance to immunotherapy.
Liu A; Curran MA
Semin Cancer Biol; 2020 Oct; 65():155-163. PubMed ID: 31982512
[TBL] [Abstract][Full Text] [Related]
16. Metabolic rewiring directs melanoma immunology.
Sun N; Tian Y; Chen Y; Guo W; Li C
Front Immunol; 2022; 13():909580. PubMed ID: 36003368
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicle-mediated crosstalk between melanoma and the immune system: Impact on tumor progression and therapy response.
Pretti MAM; Bernardes SS; da Cruz JGV; Boroni M; Possik PA
J Leukoc Biol; 2020 Oct; 108(4):1101-1115. PubMed ID: 32450618
[TBL] [Abstract][Full Text] [Related]
18. Microenvironment and tumor progression of melanoma: new therapeutic prospectives.
Botti G; Cerrone M; Scognamiglio G; Anniciello A; Ascierto PA; Cantile M
J Immunotoxicol; 2013; 10(3):235-52. PubMed ID: 23036080
[TBL] [Abstract][Full Text] [Related]
19. The Influence of Tumor Microenvironment on Immune Escape of Melanoma.
Simiczyjew A; Dratkiewicz E; Mazurkiewicz J; Ziętek M; Matkowski R; Nowak D
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171792
[TBL] [Abstract][Full Text] [Related]
20. Overcoming Immune Evasion in Melanoma.
Eddy K; Chen S
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
